Unions strike over job cuts at French vaccine maker Sanofi
Unions at French drug maker Sanofi held a one-day strike at the lab where it is developing a COVID-19 vaccine
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Unions at French drug maker Sanofi held a one-day strike Tuesday at the lab where it is developing a COVID-19 vaccine and some other sites, to protest job cuts the company plans despite a boost in investment amid the pandemic.
Some 200 workers with union flags and megaphones gathered outside the entrance to the sprawling Sanofi research and development facility in Marcy l’Etoile in central France. They said that hundreds of planned job cuts in France could slow the fight against the coronavirus pandemic.
The company announced last year it plans 1,000 job cuts across France over three years “to reinforce the effectiveness of our organization and adapt to the evolution of jobs and stakes of tomorrow.” It said in a statement Tuesday that it would rely on voluntary departures, but wouldn't comment further because of confidentiality rules amid ongoing negotiations with unions.
Union members at Sanofi also plan to join broader demonstrations Saturday in France against job cuts during the pandemic.
Sanofi, France's biggest pharmaceutical company and a world leader in vaccine development, has also come under criticism for its slow COVID-19 vaccine rollout. Sanofi and British partner GlaxoSmithKline said last month that their potential vaccine won’t be ready until late 2021 because they need to improve the shot’s effectiveness in older people.